{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:43:25Z","timestamp":1793043805360,"version":"4.5.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2006,1,19]],"date-time":"2006-01-19T00:00:00Z","timestamp":1137628800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1007\/s00277-005-0042-8","type":"journal-article","created":{"date-parts":[[2006,1,18]],"date-time":"2006-01-18T10:49:13Z","timestamp":1137581353000},"page":"226-232","source":"Crossref","is-referenced-by-count":89,"title":["Grade of bone marrow fibrosis is associated with relevant hematological findings\u2014a clinicopathological study on 865 patients with chronic idiopathic myelofibrosis"],"prefix":"10.1007","volume":"85","author":[{"given":"J.","family":"Thiele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. M.","family":"Kvasnicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,1,19]]},"reference":[{"key":"42_CR1","first-page":"228","volume":"75","author":"B Anger","year":"1990","unstructured":"Anger B, Seidler R, Haug U, Popp C, Heimpel H (1990) Idiopathic myelofibrosis: a retrospective study of 103 patients. Haematologica 75:228\u2013234","journal-title":"Haematologica"},{"key":"42_CR2","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1200\/JCO.1999.17.9.2954","volume":"17","author":"G Barosi","year":"1999","unstructured":"Barosi G (1999) Myelofibrosis with myeloid metaplasia: diagnostic definition and prognostic classification for clinical studies and treatment guidelines. J Clin Oncol 17:2954\u20132970","journal-title":"J Clin Oncol"},{"key":"42_CR3","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1046\/j.1365-2141.1999.01262.x","volume":"104","author":"G Barosi","year":"1999","unstructured":"Barosi G, Ambrosetti A, Finelli C, Grossi A, Leoni P, Liberato NL, Petti MC, Pogliani E, Ricetti M, Rupoli S, Visani G, Tura S (1999) The Italian consensus conference on diagnostic criteria for myelofibrosis with myeloid metaplasia. Br J Haematol 104:730\u2013737","journal-title":"Br J Haematol"},{"key":"42_CR4","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1365-2141.1988.tb02507.x","volume":"70","author":"G Barosi","year":"1988","unstructured":"Barosi G, Berzuini C, Liberato LN, Costa A, Polino G, Ascari E (1988) A prognostic classification of myelofibrosis with myeloid metaplasia. Br J Haematol 70:397\u2013401","journal-title":"Br J Haematol"},{"key":"42_CR5","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/ajcp\/56.1.24","volume":"56","author":"DE Bauermeister","year":"1971","unstructured":"Bauermeister DE (1971) Quantitation of bone marrow reticulin \u2014 a normal range. Am J Clin Pathol 56:24\u201331","journal-title":"Am J Clin Pathol"},{"key":"42_CR6","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(05)71142-9","volume":"365","author":"EJ Baxter","year":"2005","unstructured":"Baxter EJ, Scott LM, Campbell PJ, East C, Fourouclas N, Swanton S, Vassiliou GS, Bench AJ, Boyd EM, Curtin N, Scott MA, Erber WN, Green AR (2005) Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 365:1054\u20131061","journal-title":"Lancet"},{"key":"42_CR7","first-page":"1241","volume":"114","author":"EN Beckman","year":"1990","unstructured":"Beckman EN, Brown AW Jr (1990) Normal reticulin level in iliac bone marrow. Arch Pathol Lab Med 114:1241\u20131243","journal-title":"Arch Pathol Lab Med"},{"key":"42_CR8","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1309\/PTVGB3DXB8A8M7KD","volume":"119","author":"T Buhr","year":"2003","unstructured":"Buhr T, Buesche G, Choritz H, Langer F, Kreipe H (2003) Evolution of myelofibrosis in chronic idiopathic myelofibrosis as evidenced in sequential bone marrow biopsy specimens. Am J Clin Pathol 119:152\u2013158","journal-title":"Am J Clin Pathol"},{"key":"42_CR9","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0344-0338(11)80081-6","volume":"189","author":"T Buhr","year":"1993","unstructured":"Buhr T, Georgii A, Choritz H (1993) Myelofibrosis in chronic myeloproliferative disorders. Incidence among subtypes according to the Hannover Classification. Pathol Res Pract 189:121\u2013132","journal-title":"Pathol Res Pract"},{"key":"42_CR10","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1365-2141.2004.05301.x","volume":"128","author":"F Cervantes","year":"2005","unstructured":"Cervantes F (2005) Modern management of myelofibrosis. Br J Haematol 128:583\u2013592","journal-title":"Br J Haematol"},{"key":"42_CR11","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1046\/j.1365-2141.2002.03688.x","volume":"118","author":"F Cervantes","year":"2002","unstructured":"Cervantes F, Alvarez-Larran A, Talarn C, Gomez M, Montserrat E (2002) Myelofibrosis with myeloid metaplasia following essential thrombocythaemia: actuarial probability, presenting characteristics and evolution in a series of 195 patients. Br J Haematol 118:786\u2013790","journal-title":"Br J Haematol"},{"key":"42_CR12","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1046\/j.1365-2141.1998.00833.x","volume":"102","author":"F Cervantes","year":"1998","unstructured":"Cervantes F, Barosi G, Demory JL, Reilly J, Guarnone R, Dupriez B, Pereira A, Montserrat E (1998) Myelofibrosis with myeloid metaplasia in young individuals: disease characteristics, prognostic factors and identification of risk groups. Br J Haematol 102:684\u2013690","journal-title":"Br J Haematol"},{"key":"42_CR13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1600-0609.1998.tb01005.x","volume":"60","author":"F Cervantes","year":"1998","unstructured":"Cervantes F, Pereira A, Esteve J, Cobo F, Rozman C, Montserrat E (1998) The changing profile of idiopathic myelofibrosis: a comparison of the presenting features of patients diagnosed in two different decades. Eur J Haematol 60:101\u2013105","journal-title":"Eur J Haematol"},{"key":"42_CR14","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1046\/j.1365-2141.1997.782714.x","volume":"97","author":"F Cervantes","year":"1997","unstructured":"Cervantes F, Pereira A, Esteve J, Rafel M, Cobo F, Rozman C, Montserrat E (1997) Identification of \u2018short-lived\u2019 and \u2018long-lived\u2019 patients at presentation of idiopathic myelofibrosis. Br J Haematol 97:635\u2013640","journal-title":"Br J Haematol"},{"key":"42_CR15","first-page":"355","volume":"22","author":"JI Dickstein","year":"1995","unstructured":"Dickstein JI, Vardiman JW (1995) Hematopathologic findings in the myeloproliferative disorders. Semin Oncol 22:355\u2013373","journal-title":"Semin Oncol"},{"key":"42_CR16","doi-asserted-by":"crossref","first-page":"540","DOI":"10.2169\/internalmedicine.43.540","volume":"43","author":"D Dingli","year":"2004","unstructured":"Dingli D, Mesa RA, Tefferi A (2004) Myelofibrosis with myeloid metaplasia: new developments in pathogenesis and treatment. Intern Med 43:540\u2013547","journal-title":"Intern Med"},{"key":"42_CR17","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1182\/blood.V88.3.1013.1013","volume":"88","author":"B Dupriez","year":"1996","unstructured":"Dupriez B, Morel P, Demory JL, Lai JL, Simon M, Plantier I, Bauters F (1996) Prognostic factors in agnogenic myeloid metaplasia: a report on 195 cases with a new scoring system. Blood 88:1013\u20131018","journal-title":"Blood"},{"key":"42_CR18","first-page":"911","volume":"89","author":"AM Florena","year":"2004","unstructured":"Florena AM, Tripodo C, Iannitto E, Porcasi R, Ingrao S, Franco V (2004) Value of bone marrow biopsy in the diagnosis of essential thrombocythemia. Haematologica 89:911\u2013919","journal-title":"Haematologica"},{"key":"42_CR19","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0950-3536(98)80036-X","volume":"11","author":"A Georgii","year":"1998","unstructured":"Georgii A, Buesche G, Kreft A (1998) The histopathology of chronic myeloproliferative diseases. Baillieres Clin Haematol 11:721\u2013749","journal-title":"Baillieres Clin Haematol"},{"issue":"Suppl 1","key":"42_CR20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3109\/10428199609074357","volume":"22","author":"A Georgii","year":"1996","unstructured":"Georgii A, Buhr T, Buesche G, Kreft A, Choritz H (1996) Classification and staging of Ph-negative myeloproliferative disorders by histopathology from bone marrow biopsies. Leuk Lymphoma 22[Suppl 1]:15\u201329","journal-title":"Leuk Lymphoma"},{"key":"42_CR21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0344-0338(11)81008-3","volume":"186","author":"A Georgii","year":"1990","unstructured":"Georgii A, Vykoupil KF, Buhr T, Choritz H, Dohler U, Kaloutsi V, Werner M (1990) Chronic myeloproliferative disorders in bone marrow biopsies. Pathol Res Pract 186:3\u201327","journal-title":"Pathol Res Pract"},{"key":"42_CR22","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1182\/blood-2002-02-0485","volume":"100","author":"S Giraudier","year":"2002","unstructured":"Giraudier S, Chagraoui H, Komura E, Barnache S, Blanchet B, LeCouedic JP, Smith DF, Larbret F, Taksin AL, Moreau-Gachelin F, Casadevall N, Tulliez M, Hulin A, Debili N, Vainchenker W (2002) Overexpression of FKBP51 in idiopathic myelofibrosis regulates the growth factor independence of megakaryocyte progenitors. Blood 100:2932\u20132940","journal-title":"Blood"},{"key":"42_CR23","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1056\/NEJMp058083","volume":"352","author":"JM Goldman","year":"2005","unstructured":"Goldman JM (2005) A unifying mutation in chronic myeloproliferative disorders. N Engl J Med 352:1744\u20131746","journal-title":"N Engl J Med"},{"key":"42_CR24","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/BF02592297","volume":"23","author":"HC Hasselbalch","year":"1993","unstructured":"Hasselbalch HC (1993) Idiopathic myelofibrosis\u2014an update with particular reference to clinical aspects and prognosis. Int J Clin Lab Res 23:124\u2013138","journal-title":"Int J Clin Lab Res"},{"key":"42_CR25","first-page":"39","volume-title":"WHO classification of tumours: tumours of haematopoietic and lymphoid tissues","author":"M Imbert","year":"2001","unstructured":"Imbert M, Pierre R, Thiele J, Vardiman JW, Brunning RD, Flandrin G (2001) Essential thrombocythaemia. In: Jaffe ES, Harris NL, Stein H, Vardiman JW (eds) WHO classification of tumours: tumours of haematopoietic and lymphoid tissues. IARC Press, Lyon, pp 39\u201341"},{"key":"42_CR26","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nature03546","volume":"434","author":"C James","year":"2005","unstructured":"James C, Ugo V, Le Couedic JP, Staerk J, Delhommeau F, Lacout C, Garcon L, Raslova H, Berger R, Bennaceur-Griscelli A, Villeval JL, Constantinescu SN, Casadevall N, Vainchenker W (2005) A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature 434:1144\u20131148","journal-title":"Nature"},{"key":"42_CR27","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1182\/blood-2005-03-1320","volume":"106","author":"AV Jones","year":"2005","unstructured":"Jones AV, Kreil S, Zoi K, Waghorn K, Curtis C, Zhang L, Score J, Seear R, Chase AJ, Grand FH, White H, Zoi C, Loukopoulos D, Terpos E, Vervessou EC, Schultheis B, Emig M, Ernst T, Lengfelder E, Hehlmann R, Hochhaus A, Oscier D, Silver RT, Reiter A, Cross NC (2005) Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders. Blood 106:2162\u20132168","journal-title":"Blood"},{"key":"42_CR28","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.1182\/blood-2005-03-1287","volume":"105","author":"K Kaushansky","year":"2005","unstructured":"Kaushansky K (2005) On the molecular origins of the chronic myeloproliferative disorders: it all makes sense. Blood 105:4187\u20134190","journal-title":"Blood"},{"key":"42_CR29","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMoa051113","volume":"352","author":"R Kralovics","year":"2005","unstructured":"Kralovics R, Passamonti F, Buser AS, Teo SS, Tiedt R, Passweg JR, Tichelli A, Cazzola M, Skoda RC (2005) A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med 352:1779\u20131790","journal-title":"N Engl J Med"},{"key":"42_CR30","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000083452","volume":"113","author":"A Kreft","year":"2005","unstructured":"Kreft A, Buche G, Ghalibafian M, Buhr T, Fischer T, Kirkpatrick CJ (2005) The incidence of myelofibrosis in essential thrombocythaemia, polycythaemia vera and chronic idiopathic myelofibrosis: a retrospective evaluation of sequential bone marrow biopsies. Acta Haematol 113:137\u2013143","journal-title":"Acta Haematol"},{"key":"42_CR31","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/(SICI)1097-0142(19970815)80:4<708::AID-CNCR9>3.0.CO;2-I","volume":"80","author":"HM Kvasnicka","year":"1997","unstructured":"Kvasnicka HM, Thiele J, Werden C, Zankovich R, Diehl V, Fischer R (1997) Prognostic factors in idiopathic (primary) osteomyelofibrosis. Cancer 80:708\u2013719","journal-title":"Cancer"},{"key":"42_CR32","first-page":"409","volume":"12","author":"J Laszlo","year":"1975","unstructured":"Laszlo J (1975) Myeloproliferative disorders (MPD): myelofibrosis, myelosclerosis, extramedullary hematopoiesis, undifferentiated MPD, and hemorrhagic thrombocythemia. Semin Hematol 12:409\u2013432","journal-title":"Semin Hematol"},{"key":"42_CR33","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s002770050595","volume":"78","author":"MC Le Bousse-Kerdiles","year":"1999","unstructured":"Le Bousse-Kerdiles MC, Martyre MC (1999) Dual implication of fibrogenic cytokines in the pathogenesis of fibrosis and myeloproliferation in myeloid metaplasia with myelofibrosis. Ann Hematol 78:437\u2013444","journal-title":"Ann Hematol"},{"key":"42_CR34","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/BF00870307","volume":"21","author":"MC Le Bousse-Kerdiles","year":"1999","unstructured":"Le Bousse-Kerdiles MC, Martyre MC (1999) Myelofibrosis: pathogenesis of myelofibrosis with myeloid metaplasia. French INSERM Research Network on Myelofibrosis with Myeloid Metaplasia. Springer Semin Immunopathol 21:491\u2013508","journal-title":"Springer Semin Immunopathol"},{"key":"42_CR35","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ccr.2005.03.023","volume":"7","author":"RL Levine","year":"2005","unstructured":"Levine RL, Wadleigh M, Cools J, Ebert BL, Wernig G, Huntly BJ, Boggon TJ, Wlodarska I, Clark JJ, Moore S, Adelsperger J, Koo S, Lee JC, Gabriel S, Mercher T, D\u2019Andrea A, Frohling S, Dohner K, Marynen P, Vandenberghe P, Mesa RA, Tefferi A, Griffin JD, Eck MJ, Sellers WR, Meyerson M, Golub TR, Lee SJ, Gilliland DG (2005) Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell 7:387\u2013397","journal-title":"Cancer Cell"},{"key":"42_CR36","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-2141.1979.tb03740.x","volume":"43","author":"A Manoharan","year":"1979","unstructured":"Manoharan A, Horsley R, Pitney WR (1979) The reticulin content of bone marrow in acute leukaemia in adults. Br J Haematol 43:185\u2013190","journal-title":"Br J Haematol"},{"key":"42_CR37","first-page":"257","volume":"2","author":"MC Martyre","year":"2003","unstructured":"Martyre MC (2003) Critical review of pathogenetic mechanisms in myelofibrosis with myeloid metaplasia. Curr Hematol Rep 2:257\u2013263","journal-title":"Curr Hematol Rep"},{"key":"42_CR38","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/BF02982575","volume":"76","author":"JJ Michiels","year":"2002","unstructured":"Michiels JJ, Thiele J (2002) Clinical and pathological criteria for the diagnosis of essential thrombocythemia, polycythemia vera, and idiopathic myelofibrosis (agnogenic myeloid metaplasia). Int J Hematol 76:133\u2013145","journal-title":"Int J Hematol"},{"key":"42_CR39","first-page":"9","volume":"36","author":"S Murphy","year":"1999","unstructured":"Murphy S (1999) Diagnostic criteria and prognosis in polycythemia vera and essential thrombocythemia. Semin Hematol 36:9\u201313","journal-title":"Semin Hematol"},{"key":"42_CR40","first-page":"29","volume":"34","author":"S Murphy","year":"1997","unstructured":"Murphy S, Peterson P, Iland H, Laszlo J (1997) Experience of the Polycythemia Vera Study Group with essential thrombocythemia: a final report on diagnostic criteria, survival, and leukemic transition by treatment. Semin Hematol 34:29\u201339","journal-title":"Semin Hematol"},{"key":"42_CR41","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0950-3536(98)80035-8","volume":"11","author":"TC Pearson","year":"1998","unstructured":"Pearson TC (1998) Diagnosis and classification of erythrocytoses and thrombocytoses. Baillieres Clin Haematol 11:695\u2013720","journal-title":"Baillieres Clin Haematol"},{"key":"42_CR42","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1600-0609.1990.tb00357.x","volume":"44","author":"A Pereira","year":"1990","unstructured":"Pereira A, Cervantes F, Brugues R, Rozman C (1990) Bone marrow histopathology in primary myelofibrosis: clinical and haematologic correlations and prognostic evaluation. Eur J Haematol 44:95\u201399","journal-title":"Eur J Haematol"},{"key":"42_CR43","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1182\/blood-2004-11-4299","volume":"105","author":"D Rondelli","year":"2005","unstructured":"Rondelli D, Barosi G, Bacigalupo A, Prchal JT, Popat U, Alessandrino EP, Spivak JL, Smith BD, Klingemann HG, Fruchtman S, Hoffman R (2005) Allogeneic hematopoietic stem cell transplantation with reduced intensity conditioning in intermediate or high risk patients with myelofibrosis with myeloid metaplasia. Blood 105:4115\u20134119","journal-title":"Blood"},{"key":"42_CR44","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1002\/1097-0142(19910515)67:10<2658::AID-CNCR2820671042>3.0.CO;2-C","volume":"67","author":"C Rozman","year":"1991","unstructured":"Rozman C, Giralt M, Feliu E, Rubio D, Cortes MT (1991) Life expectancy of patients with chronic nonleukemic myeloproliferative disorders. Cancer 67:2658\u20132663","journal-title":"Cancer"},{"key":"42_CR45","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/BF01834368","volume":"68","author":"S Rupoli","year":"1994","unstructured":"Rupoli S, Da Lio L, Sisti S, Campanati G, Salvi A, Brianzoni MF, D\u2019Amico S, Cinciripini A, Leoni P (1994) Primary myelofibrosis: a detailed statistical analysis of the clinicopathological variables influencing survival. Ann Hematol 68:205\u2013212","journal-title":"Ann Hematol"},{"key":"42_CR46","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1080\/10428190290016809","volume":"43","author":"A Schmitt","year":"2002","unstructured":"Schmitt A, Drouin A, Masse JM, Guichard J, Shagraoui H, Cramer EM (2002) Polymorphonuclear neutrophil and megakaryocyte mutual involvement in myelofibrosis pathogenesis. Leuk Lymphoma 43:719\u2013724","journal-title":"Leuk Lymphoma"},{"key":"42_CR47","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1182\/blood-2005-03-1183","volume":"106","author":"DP Steensma","year":"2005","unstructured":"Steensma DP, Dewald GW, Lasho TL, Powell HL, McClure RF, Levine RL, Gilliland DG, Tefferi A (2005) The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both \u201catypical\u201d myeloproliferative disorders and the myelodysplastic syndrome. Blood 106:1207\u20131209","journal-title":"Blood"},{"key":"42_CR48","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1056\/NEJM200004273421706","volume":"342","author":"A Tefferi","year":"2000","unstructured":"Tefferi A (2000) Myelofibrosis with myeloid metaplasia. N Engl J Med 342:1255\u20131265","journal-title":"N Engl J Med"},{"key":"42_CR49","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3109\/10428199409049664","volume":"14","author":"J Thiele","year":"1994","unstructured":"Thiele J, Chen YS, Kvasnicka HM, Diehl V, Fischer R (1994) Evolution of fibro-osteosclerotic bone marrow lesions in primary (idiopathic) osteomyelofibrosis\u2014a histomorphometric study on sequential trephine biopsies. Leuk Lymphoma 14:163\u2013169","journal-title":"Leuk Lymphoma"},{"key":"42_CR50","first-page":"35","volume-title":"WHO classification of tumours: tumours of haematopoietic and lymphoid tissues","author":"J Thiele","year":"2001","unstructured":"Thiele J, Imbert M, Pierre R, Vardiman JW, Brunning RD, Flandrin G (2001) Chronic idiopathic myelofibrosis. In: Jaffe ES, Harris NL, Stein H, Vardiman JW (eds) WHO classification of tumours: tumours of haematopoietic and lymphoid tissues. IARC Press, Lyon, pp 35\u201338"},{"key":"42_CR51","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s00277-002-0604-y","volume":"82","author":"J Thiele","year":"2003","unstructured":"Thiele J, Kvasnicka HM (2003) Chronic myeloproliferative disorders with thrombocythemia: a comparative study of two classification systems (PVSG, WHO) on 839 patients. Ann Hematol 82:148\u2013152","journal-title":"Ann Hematol"},{"key":"42_CR52","first-page":"93","volume":"18","author":"J Thiele","year":"2003","unstructured":"Thiele J, Kvasnicka HM (2003) Diagnostic differentiation of essential thrombocythaemia from thrombocythaemias associated with chronic idiopathic myelofibrosis by discriminate analysis of bone marrow features\u2014a clinicopathological study on 272 patients. Histol Histopathol 18:93\u2013102","journal-title":"Histol Histopathol"},{"key":"42_CR53","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000076524","volume":"111","author":"J Thiele","year":"2004","unstructured":"Thiele J, Kvasnicka HM (2004) Prefibrotic chronic idiopathic myelofibrosis\u2014a diagnostic enigma? Acta Haematol 111:155\u2013159","journal-title":"Acta Haematol"},{"key":"42_CR54","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1038\/sj.leu.2401553","volume":"13","author":"J Thiele","year":"1999","unstructured":"Thiele J, Kvasnicka HM, Boeltken B, Zankovich R, Diehl V, Fischer R (1999) Initial (prefibrotic) stages of idiopathic (primary) myelofibrosis (IMF)\u2014a clinicopathological study. Leukemia 13:1741\u20131748","journal-title":"Leukemia"},{"key":"42_CR55","first-page":"633","volume":"20","author":"J Thiele","year":"2005","unstructured":"Thiele J, Kvasnicka HM, Diehl V (2005) Standardization of bone marrow features\u2014does it work in hematopathology for histological discrimination of different disease patterns? Histol Histopathol 20:633\u2013644","journal-title":"Histol Histopathol"},{"key":"42_CR56","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3109\/10428199909058421","volume":"33","author":"J Thiele","year":"1999","unstructured":"Thiele J, Kvasnicka HM, Diehl V, Fischer R, Michiels J (1999) Clinicopathological diagnosis and differential criteria of thrombocythemias in various myeloproliferative disorders by histopathology, histochemistry and immunostaining from bone marrow biopsies. Leuk Lymphoma 33:207\u2013218","journal-title":"Leuk Lymphoma"},{"key":"42_CR57","first-page":"1128","volume":"90","author":"J Thiele","year":"2005","unstructured":"Thiele J, Kvasnicka HM, Facchetti F, Franco V, Van der Walt J, Orazi A (2005) European consensus for grading of bone marrow fibrosis and assessment of cellularity. Haematologica 90:1128\u20131132","journal-title":"Haematologica"},{"key":"42_CR58","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/ajh.10116","volume":"70","author":"J Thiele","year":"2002","unstructured":"Thiele J, Kvasnicka HM, Schmitt-Graeff A, Zankovich R, Diehl V (2002) Follow-up examinations including sequential bone marrow biopsies in essential thrombocythemia (ET): a retrospective clinicopathological study of 120 patients. Am J Hematol 70:283\u2013291","journal-title":"Am J Hematol"},{"key":"42_CR59","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1080\/1042819031000077070","volume":"44","author":"J Thiele","year":"2003","unstructured":"Thiele J, Kvasnicka HM, Schmitt-Gr\u00e4ff A, Diehl V (2003) Dynamics of fibrosis in chronic idiopathic (primary) myelofibrosis during therapy: a follow-up study on 309 patients. Leuk Lymphoma 44:549\u2013553","journal-title":"Leuk Lymphoma"},{"key":"42_CR60","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3109\/10428199209053572","volume":"6","author":"J Thiele","year":"1992","unstructured":"Thiele J, Kvasnicka HM, Steinberg T, Zankovich R, Fischer R, Diehl V (1992) Survival in primary (idiopathic) osteomyelofibrosis, so-called agnogenic myeloid metaplasia. Leuk Lymphoma 6:389\u2013399","journal-title":"Leuk Lymphoma"},{"key":"42_CR61","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3109\/10428199609051762","volume":"22","author":"J Thiele","year":"1996","unstructured":"Thiele J, Kvasnicka HM, Werden C, Zankovich R, Diehl V, Fischer R (1996) Idiopathic primary osteo-myelofibrosis: a clinico-pathological study on 208 patients with special emphasis on evolution of disease features, differentiation from essential thrombocythemia and variables of prognostic impact. Leuk Lymphoma 22:303\u2013317","journal-title":"Leuk Lymphoma"},{"key":"42_CR62","first-page":"1126","volume":"85","author":"J Thiele","year":"2000","unstructured":"Thiele J, Kvasnicka HM, Zankovich R, Diehl V (2000) Relevance of bone marrow features in the differential diagnosis between essential thrombocythemia and early stage idiopathic myelofibrosis. Haematologica 85:1126\u20131134","journal-title":"Haematologica"},{"key":"42_CR63","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1080\/10428190290021542","volume":"43","author":"J Thiele","year":"2002","unstructured":"Thiele J, Kvasnicka HM, Zankovich R, Diehl V (2002) Early-stage idiopathic (primary) myelofibrosis\u2014current issues of diagnostic features. Leuk Lymphoma 43:1035\u20131041","journal-title":"Leuk Lymphoma"},{"key":"42_CR64","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/hon.2900070502","volume":"7","author":"J Thiele","year":"1989","unstructured":"Thiele J, Zankovich R, Steinberg T, Fischer R, Diehl V (1989) Agnogenic myeloid metaplasia (AMM)\u2014correlation of bone marrow lesions with laboratory data: a longitudinal clinicopathological study on 114 patients. Hematol Oncol 7:327\u2013343","journal-title":"Hematol Oncol"},{"key":"42_CR65","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1182\/blood-2004-04-1320","volume":"105","author":"AM Vannucchi","year":"2005","unstructured":"Vannucchi AM, Bianchi L, Paoletti F, Pancrazzi A, Torre E, Nishikawa M, Zingariello M, Di Baldassarre A, Rana RA, Lorenzini R, Alfani E, Migliaccio G, Migliaccio AR (2005) A pathobiologic pathway linking thrombopoietin, GATA-1, and TGF-{beta}1 in the development of myelofibrosis. Blood 105:3493\u20133501","journal-title":"Blood"},{"key":"42_CR66","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0740-2570(03)00025-X","volume":"20","author":"JW Vardiman","year":"2003","unstructured":"Vardiman JW (2003) Myelodysplastic syndromes, chronic myeloproliferative diseases, and myelodysplastic\/myeloproliferative diseases. Semin Diagn Pathol 20:154\u2013179","journal-title":"Semin Diagn Pathol"},{"key":"42_CR67","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1365-2141.1990.tb02609.x","volume":"75","author":"G Visani","year":"1990","unstructured":"Visani G, Finelli C, Castelli U, Petti MC, Ricci P, Vianelli N, Gianni L, Zuffa E, Aloe Spiriti MA, Latagliata R et al (1990) Myelofibrosis with myeloid metaplasia: clinical and haematological parameters predicting survival in a series of 133 patients. Br J Haematol 75:4\u20139","journal-title":"Br J Haematol"},{"key":"42_CR68","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1182\/blood.V65.4.803.803","volume":"65","author":"BC Wolf","year":"1985","unstructured":"Wolf BC, Neiman RS (1985) Myelofibrosis with myeloid metaplasia: pathophysiologic implications of the correlation between bone marrow changes and progression of splenomegaly. Blood 65:803\u2013809","journal-title":"Blood"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-005-0042-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-005-0042-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-005-0042-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,12]],"date-time":"2020-04-12T04:47:28Z","timestamp":1586666848000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-005-0042-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1,19]]},"references-count":68,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["42"],"URL":"https:\/\/doi.org\/10.1007\/s00277-005-0042-8","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,1,19]]}}}